0001209191-19-054530.txt : 20191030
0001209191-19-054530.hdr.sgml : 20191030
20191030170558
ACCESSION NUMBER: 0001209191-19-054530
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191029
FILED AS OF DATE: 20191030
DATE AS OF CHANGE: 20191030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Jonathan S.
CENTRAL INDEX KEY: 0001791944
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 191181045
MAIL ADDRESS:
STREET 1: C/O PHATHOM PHARMACEUTICALS, INC.
STREET 2: 2150 E. LAKE COOK ROAD, SUITE 800
CITY: BUFFALO GROVE
STATE: IL
ZIP: 60089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 E. LAKE COOK ROAD, SUITE 800
CITY: BUFFALO GROVE
STATE: IL
ZIP: 60089
BUSINESS PHONE: 650-325-5156
MAIL ADDRESS:
STREET 1: 2150 E. LAKE COOK ROAD, SUITE 800
CITY: BUFFALO GROVE
STATE: IL
ZIP: 60089
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-29
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001791944
Edwards Jonathan S.
C/O PHATHOM PHARMACEUTICALS, INC.
2150 E. LAKE COOK ROAD, SUITE 800
BUFFALO GROVE
IL
60089
1
0
0
0
Common Stock
2019-10-29
4
C
0
991672
15.20
A
991672
I
By Medicxi Growth I LP
Common Stock
2019-10-29
4
C
0
23558
15.20
A
23558
I
By Medicxi Growth Co-Invest I LP
Common Stock
2019-10-29
4
P
0
1028205
19.00
A
2019877
I
By Medicxi Growth I LP
Common Stock
2019-10-29
4
P
0
24426
19.00
A
47984
I
By Medicxi Growth Co-Invest I LP
Convertible Promissory Notes
15.20
2019-10-29
4
C
0
15073416.76
0.00
D
2020-05-07
Common Stock
991672
0
I
By Medicxi Growth I LP
Convertible Promissory Notes
15.20
2019-10-29
4
C
0
358090.10
0.00
D
2020-05-07
Common Stock
23558
0
I
By Medicxi Growth Co-Invest I LP
Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock.
Held by Medicxi Growth I LP ("Medicxi Growth I"). Medicxi Growth I GP Limited ("Medicxi Growth I GP") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP ("Medicxi Growth Co-Invest I"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Exhibit 24 - Power of Attorney (incorporated by reference to Exhibit 24 - Power of Attorney included on the Form 3, filed with the SEC on October 24, 2019).
/s/ David Socks, Attorney-in-Fact
2019-10-30